Back to Search Start Over

AML-437 Real-World Effectiveness of Enasidenib (ENA) in Older Patients With Relapsed/Refractory (R/R) Isocitrate Dehydrogenase-2 (IDH2)-Mutated Acute Myeloid Leukemia (AML)

Authors :
Ali McBride
Andrew J. Klink
Amanda J. Ullman
Djibril Liassou
Cherrishe Brown-Bickerstaff
Ajeet Gajra
Source :
Clinical Lymphoma Myeloma and Leukemia. 22:S250-S251
Publication Year :
2022
Publisher :
Elsevier BV, 2022.

Subjects

Subjects :
Cancer Research
Oncology
Hematology

Details

ISSN :
21522650
Volume :
22
Database :
OpenAIRE
Journal :
Clinical Lymphoma Myeloma and Leukemia
Accession number :
edsair.doi...........b6ceef72b490091b7251cf679b06c744
Full Text :
https://doi.org/10.1016/s2152-2650(22)01295-2